Benchmarking Diabetes Technology Use Among 21 U.S. Pediatric Diabetes Centers.
| Autor: | Prahalad P; Stanford Children's Health, Lucile Packard Children's Hospital, Stanford, CA., Hardison H; T1D Exchange, Boston, MA., Odugbesan O; T1D Exchange, Boston, MA., Lyons S; Baylor College of Medicine/Texas Children's Hospital, Houston, TX., Alwazeer M; Cook Children's, Endocrinology, Fort Worth, TX., Neyman A; UH Rainbow Babies & Children's Hospital, Cleveland, OH., Miyazaki B; Children's Hospital of Los Angeles, Los Angeles, CA., Cossen K; Children's Healthcare of Atlanta, Atlanta, GA., Hsieh S; Cook Children's, Endocrinology, Fort Worth, TX., Eng D; Pediatric Endocrinology, Spectrum Health, Helen DeVos Children's Hospital, Grand Rapids, MI., Roberts A; Seattle Children's Hospital, Seattle, WA., Clements MA; Children's Mercy Hospital, Kansas City, MO., Ebekozien O; T1D Exchange, Boston, MA.; University of Mississippi School of Population Health, Jackson, MS. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Clinical diabetes : a publication of the American Diabetes Association [Clin Diabetes] 2024 Winter; Vol. 42 (1), pp. 27-33. Date of Electronic Publication: 2023 Nov 01. |
| DOI: | 10.2337/cd23-0052 |
| Abstrakt: | The American Diabetes Association's Standards of Care in Diabetes recommends the use of diabetes technology such as continuous glucose monitoring systems and insulin pumps for people living with type 1 diabetes. Unfortunately, there are multiple barriers to uptake of these devices, including local diabetes center practices. This study aimed to examine overall change and center-to-center variation in uptake of diabetes technology across 21 pediatric centers in the T1D Exchange Quality Improvement Collaborative. It found an overall increase in diabetes technology use for most centers from 2021 to 2022 with significant variation. Competing Interests: M.A.C. is the chief medical officer of Glooko and receives research support from Abbott Diabetes Care and Dexcom. O.E. is a Diabetes Health Equity Advisory Board member for Medtronic; his organization, T1D Exchange, has received research support on his behalf from Abbott, Dexcom, Eli Lilly, Medtronic Diabetes, and Vertex; and he has received honoraria from Medtronic Diabetes and Vertex. No other potential conflicts of interest relevant to this article were reported. (© 2024 by the American Diabetes Association.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|